Holistic Integrative Oncology（HIO，eISSN:2731-4529; CN12-1481/R73）是由中国抗癌协会与Springer Nature出版集团于2021年强强联合打造的一本英文大刊，主编为中国抗癌协会理事长樊代明院士。HIO入选了2022年中国科技期刊卓越行动计划高起点新刊项目，是面向全球开放的自由获取同行评议期刊，设有CACA指南、专家述评、研究综述和原创论著等栏目。黑色素瘤专题文章已正式上线，敬请各位读者阅读、引用与分享！
本专题目录
01 CACA guidelines for holistic integrative management of anticancer treatment - induced cutaneous adverse events
文章类型：Guideline
引用格式：Zhu, G., Shi, Q., Cai, T. et al. CACA guidelines for holistic integrative management of anticancer treatment - induced cutaneous adverse events. Holist Integ Oncol 3, 33 (2024). https://doi.org/10.1007/s44178-024-00095-8
文章链接：https://link.springer.com/article/10.1007/s44178-024-00095-8
02 Recent advances in the treatment of pancreatic cancer
文章类型：Commentary
引用格式：Ma, Y., Zhang, F. & Yang, Y. Recent advances in the treatment of pancreatic cancer. Holist Integ Oncol 3, 34 (2024). https://doi.org/10.1007/s44178-024-00089-6
文章链接：https://link.springer.com/article/10.1007/s44178-024-00089-6
03 Use of 125 iodine seeds for intra-operative localization of nonpalpable breast lesions (ROLLIS): analysis of the implant of 1757 seeds in 1477 patients
文章类型：Commentary
引用格式：Penna, A.C., da Silva Franca, C.A., de Oliveira, M.V.F.T. et al. Use of 125 iodine seeds for intra-operative localization of nonpalpable breast lesions (ROLLIS): analysis of the implant of 1757 seeds in 1477 patients. Holist Integ Oncol 3, 30 (2024). https://doi.org/10.1007/s44178-024-00103-x
文章链接：https://link.springer.com/article/10.1007/s44178-024-00103-x
04 Potential role of cyclin-dependent kinase 4/6 inhibitors in the treatment of mucosal melanoma
文章类型：Review
引用格式：Shi, C., Ju, H., Wu, Y. et al. Potential role of cyclin-dependent kinase 4/6 inhibitors in the treatment of mucosal melanoma. Holist Integ Oncol 3, 24 (2024). https://doi.org/10.1007/s44178-024-00090-z
文章链接：https://link.springer.com/article/10.1007/s44178-024-00090-z
05 Transcriptional dysregulation and insights into clinical implications in melanoma
文章类型：Review
引用格式：Shen, C., Chen, M., Nian, X. et al. Transcriptional dysregulation and insights into clinical implications in melanoma. Holist Integ Oncol 3, 28 (2024). https://doi.org/10.1007/s44178-024-00091-y
文章链接：https://link.springer.com/article/10.1007/s44178-024-00091-y
06 Advances in predictive biomarkers for melanoma immunotherapy
文章类型：Review
引用格式：Ma, W., Liu, W., Zhong, J. et al. Advances in predictive biomarkers for melanoma immunotherapy. Holist Integ Oncol 3, 48 (2024). https://doi.org/10.1007/s44178-024-00121-9
文章链接：https://link.springer.com/article/10.1007/s44178-024-00121-9
07 Real-world clinical outcome and safety of adjuvant human Interferon-alpha1b in resected stage IIIB or IIIC melanoma: results of a retrospective study
文章类型：Original Research
引用格式：Gao, M., Li, Y., Tang, W. et al. Real-world clinical outcome and safety of adjuvant human Interferon-alpha1b in resected stage IIIB or IIIC melanoma: results of a retrospective study. Holist Integ Oncol 3, 21 (2024). https://doi.org/10.1007/s44178-024-00087-8
文章链接：https://link.springer.com/article/10.1007/s44178-024-00087-8
08 MIIP downregulates PD-L1 expression through HDAC6 in cutaneous melanoma
文章类型：Original Research
引用格式：Li, T., Xing, R., Xiang, L. et al. MIIP downregulates PD-L1 expression through HDAC6 in cutaneous melanoma. Holist Integ Oncol 3, 25 (2024). https://doi.org/10.1007/s44178-024-00094-9
文章链接：https://link.springer.com/article/10.1007/s44178-024-00094-9
09 A novel survival nomogram for stage I-III acral lentiginous melanoma patients, based on the SEER database and a multi-center external validation cohort
文章类型：Original Research
引用格式：Li, T., Sun, W., Luo, Y. et al. A novel survival nomogram for stage I-III acral lentiginous melanoma patients, based on the SEER database and a multi-center external validation cohort. Holist Integ Oncol 3, 23 (2024). https://doi.org/10.1007/s44178-024-00092-x
文章链接：https://link.springer.com/article/10.1007/s44178-024-00092-x
欢迎投稿
HIO诚挚邀请各位专家学者积极投稿！
期刊主页：https://www.springer.com/journal/44178/
投稿链接：https://www.editorialmanager.com/hion/default2.aspx
编辑部邮箱：hio@caca.org.cn
|
